A US Food and Drug Administration panel has recommended against labeling that would make it appropriate to use 1 bottle of drops for 2 eyes postoperatively. Medscape Medical News
Day: February 28, 2012
Potential Major Breakthrough in Treatment of Wet Age-Related Macular Degeneration
A single injection of a new gene therapy treatment from Avalanche Biotech could possibly stop the advance of neovascularization in the wet form of AMD for several years. Human clinical trials are currently underway. Here is how I commented about this breakthrough in my writeup: “If this approach is successful, it could result in a […]
Bevacizumab Prevents Posttrabeculectomy Complications
The antiangiogenesis agent bevacizumab had an 80% success rate in the maintenance of postoperative improvement in intraocular pressure (IOP) after trabeculectomy. In addition, the drug reduced the incidence of subconjunctival scarring, according to fin…
pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida announces positive outcome to European Decentralized procedure for approval for ILUVIEN for treatment of chronic diabetic macular edema
Dompé enters definitive agreement to acquire Anabasis
Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular …